Literature DB >> 11079637

Prevalence of suicide programs in schools and roadblocks to implementation.

D C Hayden1, P Lauer.   

Abstract

We surveyed all school districts in Washington State for information on the prevalence of suicide programs and on major roadblocks to implementing programs. With 163 districts responding (62%), we found that the majority did not have suicide programs or policies and procedures. The largest perceived roadblock was insufficient staff and the greatest perceived need was more information. Although establishing policies and procedures is considered by many as a necessary first step to establishing suicide programs, we did not find schools choosing this option as often as others. This raises questions as to what are effective ways to have schools start suicide programs. We analyzed the data by school district size and by the title of the staff member making the report. We discuss the implications of these findings as well as the need for further efforts to develop appropriate programs for schools.

Entities:  

Mesh:

Year:  2000        PMID: 11079637

Source DB:  PubMed          Journal:  Suicide Life Threat Behav        ISSN: 0363-0234


  3 in total

1.  Should we ask our Children about Sex, Drugs and Rock & Roll?: Potentially Harmful Effects of Asking Questions About Risky Behaviors.

Authors:  Gavan J Fitzsimons; Sarah G Moore
Journal:  J Consum Psychol       Date:  2008-04-01

2.  Feasibility of screening adolescents for suicide risk in "real-world" high school settings.

Authors:  Denise Hallfors; Paul H Brodish; Shereen Khatapoush; Victoria Sanchez; Hyunsan Cho; Allan Steckler
Journal:  Am J Public Health       Date:  2005-12-27       Impact factor: 9.308

Review 3.  School-based gatekeeper training programmes in enhancing gatekeepers' cognitions and behaviours for adolescent suicide prevention: a systematic review.

Authors:  Phoenix K H Mo; Ting Ting Ko; Mei Qi Xin
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2018-06-07       Impact factor: 3.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.